Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2025-12-24 @ 6:38 PM
NCT ID:
NCT06728657
Eligibility Criteria:
Inclusion Criteria:
* Histopathologically confirmed adenocarcinoma of proximal stomach (G) or gastroesophageal junction (GEJ) (excluding Siewert type I).
* Potentially resectable, cT3-4aN+M0 or cT4bNanyM0.
* Exclusion of peritoneal metastasis through laparoscopic exploration or FAPI PET/CT.
* The status of HER2, MMR, EBER is clear.
* Male or female. Patient age ≥ 18 years and ≤ 75 years.
* Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) score of 0 or 1.
* Physical state or organ function can tolerate the planned treatment of the study protocol.
* No previous surgery or antitumor therapies, including chemotherapy, radiotherapy, or immunotherapy, were administered.
* Patients agree to sign written informed consent before recruitment.
Exclusion Criteria:
* Pregnancy or breastfeeding women.
* History of other malignancies within 5 years.
* Serious medical illness, such as severe mental disorders, cardiac disease, uncontrolled infection, etc.
* Immunodeficiency disease or long-term using of immunosuppressive agents.
* Allergic to any component of the therapy.
* Any other condition or disease that is not suitable to take the therapy included in the protocol.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT06728657
Study Brief:
Protocol Section:
NCT06728657